IMMUCHEM GAL-MW EA

Enzymatic Methods, Galactose

ICN PHARMACEUTICALS, INC.

The following data is part of a premarket notification filed by Icn Pharmaceuticals, Inc. with the FDA for Immuchem Gal-mw Ea.

Pre-market Notification Details

Device IDK951329
510k NumberK951329
Device Name:IMMUCHEM GAL-MW EA
ClassificationEnzymatic Methods, Galactose
Applicant ICN PHARMACEUTICALS, INC. 3300 HYLAND AVE. Costa Mesa,  CA  92626
ContactRobin J Hellen
CorrespondentRobin J Hellen
ICN PHARMACEUTICALS, INC. 3300 HYLAND AVE. Costa Mesa,  CA  92626
Product CodeJIA  
CFR Regulation Number862.1310 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1995-03-23
Decision Date1995-11-09

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00840239014894 K951329 000
00840239014887 K951329 000
00840239014870 K951329 000
00840239014863 K951329 000
00817830023129 K951329 000
00817830023112 K951329 000
00817830023105 K951329 000
00817830023099 K951329 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.